Skip to main content

Global Apheresis Market to Achieve 8% CAGR as Therapeutic Procedures Gain Momentum 2030

 


The global apheresis market is expected to grow at a CAGR of ~8% during the forecast period. The market expansion is driven by the increasing prevalence of chronic and autoimmune diseases, growing demand for blood components, and advancements in apheresis technologies. Additionally, rising awareness about blood donation is fostering market growth. However, the high cost of apheresis procedures and devices, along with stringent regulatory requirements, pose challenges to market expansion. 

Apheresis is a medical procedure that involves the separation of blood components to remove or collect specific elements while returning the remaining blood to the patient. This technique is widely used for therapeutic and donation purposes, including the extraction of plasma, platelets, leukocytes, and red blood cells. In therapeutic apheresis, the procedure is employed to treat conditions such as autoimmune disorders, leukemia, and metabolic diseases by removing pathogenic substances. Additionally, apheresis plays a crucial role in blood banking and transfusion medicine, ensuring the availability of vital blood components for medical treatments.

🔗 Want deeper insights? Download the sample report here:
https://meditechinsights.com/apheresis-market/request-sample/

Expanding use of apheresis in chronic disease management

One of the primary factors driving the demand for apheresis is the rising prevalence of chronic diseases, particularly autoimmune disorders, hematologic malignancies, and metabolic conditions. Apheresis is frequently used in treating conditions such as Guillain-Barré syndrome, myasthenia gravis, and thrombotic thrombocytopenic purpura, where conventional treatments may be less effective. The increasing burden of chronic kidney disease (CKD) and cardiovascular disorders has also escalated the demand for therapeutic plasma exchange and LDL apheresis. Furthermore, the expanding applications of apheresis in regenerative medicine and stem cell therapies contribute to its adoption in clinical settings. With the aging population and rising disease burden, healthcare providers are increasingly integrating apheresis as a critical component of patient management, reinforcing its demand across hospitals and specialty clinics.

Advancements in apheresis improving precision and clinical outcomes

Significant technological advancements in apheresis systems are playing a crucial role in market expansion. Innovations such as automation, improved membrane filtration techniques, and software-integrated devices have enhanced the efficiency and safety of apheresis procedures. The introduction of selective apheresis, which allows for the precise removal of specific disease-causing factors, has broadened therapeutic applications. Additionally, the development of portable and point-of-care apheresis devices has improved accessibility, particularly in home healthcare and ambulatory settings. Another major advancement is integrating artificial intelligence (AI) and machine learning (ML) in apheresis systems, enabling real-time monitoring and personalized treatment adjustments. These technological innovations are improving patient outcomes, reducing procedure times, and expanding the scope of apheresis in clinical practice, thereby driving the market forward.

Competitive Landscape Analysis

The global apheresis market is marked by the presence of established and emerging market players such as Fresenius SE & Co. KGaA; Haemonetics Corporation; Asahi Kasei Medical Co., Ltd.; Terumo BCT, Inc.; Baxter International Inc.; Becton, Dickinson and Company; Medica S.p.A; B. Braun Melsungen AG; Mallinckrodt Plc; and Nikkiso Co., Ltd. among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

Get PDF Report for Competitive Analysis: 
https://meditechinsights.com/apheresis-market/request-sample/

Global Apheresis Market Segmentation

This report by Medi-Tech Insights provides the size of the global apheresis market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product, procedure, technology, application and end-user.

Market Size & Forecast (2023-2030), By Product, USD Million

  • Devices
  • Disposables & Consumables

Market Size & Forecast (2023-2030), By Procedure, USD Million

  • Plasmapheresis
  • Plateletpheresis
  • Leukapheresis
  • Photopheresis
  • Erythrocytapheresis
  • Others
  • Market a& Forecast (2023-2030), By Technology, USD Million
  • Centrifugation
  • Membrane Separation

Market Size & Forecast (2023-2030), By Application, USD Million

  • Renal Disorders
  • Neurological Disorders
  • Hematological Disorders
  • Autoimmune Disorders
  • Others

Market Size & Forecast (2023-2030), By End-user, USD Million

  • Hospitals
  • Blood Banks
  • Specialty Clinics
  • Others

Market Size & Forecast (2023-2030), By Region, USD Million

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com 

Comments

Post a Comment

Popular posts from this blog

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

  The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years.  Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop r...
Post a Comment
Read more

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...
Post a Comment
Read more

Global Cell Isolation Market projected to grow at 11% CAGR with R&D in oncology therapies by 2030

  The global cell isolation market is projected to grow at a CAGR of 11% from 2025 to 2030,  driven by rising investments in cell-based research, increasing adoption of cell therapies, and growing demand for biopharmaceutical production. Growth is further supported by technological advancements in isolation methods, increasing R&D activities in regenerative medicine, and expanding clinical applications for isolated cells.  Cell isolation is a fundamental process in life sciences and clinical research, involving the separation of specific cell types from complex biological samples. The market is expanding due to growing applications in stem cell research, cancer biology, immunology, and personalized medicine. Additionally, improvements in magnetic-activated cell sorting (MACS), fluorescence-activated cell sorting (FACS), and microfluidic technologies are making cell isolation more efficient, reproducible, and scalable. To request a free sample copy of this report,...
Post a Comment
Read more